HHDFX
Price
$39.83
Change
-$0.08 (-0.20%)
Updated
Jul 31 closing price
Net Assets
1.85B
RMEBX
Price
$64.44
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
Interact to see
Advertisement

HHDFX vs RMEBX

HHDFX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
HHDFX vs. RMEBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HHDFX is a Hold and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. HHDFX (1.85B). HHDFX pays higher dividends than RMEBX: HHDFX (2.23) vs RMEBX (0.99). HHDFX was incepted earlier than RMEBX: HHDFX (14 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than HHDFX (0.95). RMEBX is a more actively managed with annual turnover of: 30.00 vs. HHDFX (23.00). RMEBX has a lower initial minimum investment than HHDFX: RMEBX (250) vs HHDFX (100000). HHDFX annual gain was more profitable for investors over the last year : 14.36 vs. RMEBX (8.96). HHDFX return over 5 years is better than : 56.99 vs. RMEBX (36.13).
HHDFXRMEBXHHDFX / RMEBX
Total Expense Ratio0.851.0779%
Annual Report Gross Expense Ratio0.951.0789%
Fund Existence14 years12 years-
Gain YTD12.6029.416134%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.85B118B2%
Annual Yield % from dividends2.230.99225%
Returns for 1 year14.368.96160%
Returns for 3 years40.5232.63124%
Returns for 5 years56.9936.13158%
Returns for 10 years149.3090.64165%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOTX15.100.17
+1.14%
Voya Large Cap Growth Port S2
JRAAX88.86N/A
N/A
Janus Henderson Research A
VLLIX45.39-0.03
-0.07%
Value Line Larger Companies Focus Instl
BHCFX21.68-0.10
-0.46%
Baron Health Care Retail
FBDIX193.96-3.99
-2.02%
Franklin Biotechnology Discovery A